Triterpenoids-templated self-assembly nanosystem for biomimetic delivery of CRISPR/Cas9 based on the synergy of TLR-2 and ICB to enhance HCC immunotherapy
Combination immunotherapy has shown promising potential for enhancing the objective response rate compared to immune checkpoint blockade (ICB) monotherapy. However, combination therapy with multi-drugs is limited by the different properties of the agents and inconsistent synergistic targeted deliver...
Saved in:
Main Authors: | Bing-Chen Zhang (Author), Chun-Mei Lai (Author), Bang-Yue Luo (Author), Jing-Wei Shao (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A smart dual-drug nanosystem based on co-assembly of plant and food-derived natural products for synergistic HCC immunotherapy
by: Bingchen Zhang, et al.
Published: (2021) -
The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo
by: Su-Ru Lin, et al.
Published: (2014) -
Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?
by: He X, et al.
Published: (2022) -
High Efficiency Gene Correction in Hematopoietic Cells by Donor-Template-Free CRISPR/Cas9 Genome Editing
by: Duran Sürün, et al.
Published: (2018) -
CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy
by: January Salas-Mckee, et al.
Published: (2019)